SenesTech Inc
$ 2.11
-1.86%
24 Feb - close price
- Market Cap 11,229,500 USD
- Current Price $ 2.11
- High / Low $ 2.29 / 2.10
- Stock P/E N/A
- Book Value 2.17
- EPS -2.21
- Next Earning Report 2026-03-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.38 %
- ROE -0.78 %
- 52 Week High 6.24
- 52 Week Low 1.30
About
SenesTech, Inc. develops a technology for managing animal pest populations by controlling fertility. The company is headquartered in Phoenix, Arizona.
Analyst Target Price
$10.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-08 | 2025-05-07 | 2025-03-12 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-02-21 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-16 |
| Reported EPS | -0.28 | -0.87 | -1.2808 | -1.22 | -2.07 | -3.08 | -0.36 | -0.9 | -0.47 | -0.7 | -1.32 | -3.21 |
| Estimated EPS | -0.35 | None | None | -1.5 | -3.2 | -3.2 | -0.34 | -0.44 | -0.85 | -0.78 | -0.81 | -4.2 |
| Surprise | 0.07 | 0 | 0 | 0.28 | 1.13 | 0.12 | -0.02 | -0.46 | 0.38 | 0.08 | -0.51 | 0.99 |
| Surprise Percentage | 20% | None% | None% | 18.6667% | 35.3125% | 3.75% | -5.8824% | -104.5455% | 44.7059% | 10.2564% | -62.963% | 23.5714% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-11 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SNES
2026-02-20 02:37:32
Glenbrook Capital Management, a significant shareholder in SenesTech (NASDAQ:SNES), has increased its holdings by purchasing 85,901 shares for over $200,634 between February 17 and February 19, 2026. These purchases occurred as SenesTech's stock showed strong momentum, returning 20% in the past week. The company has also recently announced strategic moves including enhanced e-commerce operations, regulatory approval in New Zealand for its Evolve product, and upcoming CEO retirement.
2026-02-20 01:26:51
Glenbrook Capital Management, a significant owner of SenesTech, Inc. (NASDAQ:SNES), recently acquired an additional 85,901 shares of the company's common stock for a total of $200,634. These transactions took place between February 17 and February 19, 2026, with prices ranging from $2.29 to $2.402 per share. Following these purchases, Glenbrook Capital Management now directly holds 704,211 shares of SenesTech, which is currently trading near its InvestingPro Fair Value estimate.
2026-02-20 00:56:46
Glenbrook Capital Management, a major shareholder in SenesTech (SNES), recently acquired an additional 85,901 shares for over $200,634 between February 17 and 19, 2026. These purchases increased Glenbrook Capital's direct holdings to 704,211 shares, coinciding with a 20% stock return over the past week and other company developments like e-commerce expansion and a CEO retirement announcement. SenesTech's stock currently trades near its InvestingPro Fair Value estimate.
2026-02-18 12:58:07
SenesTech (NASDAQ: SNES) reported significant reductions in rodent activity in urban field studies using its Evolve® Rat Birth Control. One location saw an 79% reduction in plate presence and 88% decrease in track density, while another experienced over 50% reduction in presence and 71% density decline over five months. These results provide real-world efficacy data for fertility control as part of integrated pest management.
2026-02-18 08:00:00
SenesTech, Inc. announced significant reductions in rodent activity following the deployment of its Evolve® Rat Birth Control in two urban locations. Field studies showed reductions in rodent presence and activity levels, with one location achieving a 79% reduction in plate presence and 88% decrease in track density, and another showing over a 50% reduction in presence and 71% in track density within five months. These results highlight the effectiveness of fertility control as part of integrated pest management programs.
2026-02-11 07:58:30
SenesTech, Inc. (NASDAQ:SNES) announced it will directly manage Amazon sales of its Evolve Rat and Evolve Mouse products, effective immediately. This strategic change aims to enhance e-commerce operations, which represented over 50% of the company's 2025 revenue. By taking control of product presentation and customer communication, SenesTech expects to retain a larger portion of e-commerce revenue, with financial benefits anticipated to grow significantly in Q2 2026.
